|
Volumn 37, Issue 15, 2001, Pages 1828-1832
|
A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomas
|
Author keywords
Biliary tract cancer; Cancer of unknown primary site; Chemotherapy; Gastric cancer; Oesophageal cancer; Pancreatic cancer; Weekly 5 FU
|
Indexed keywords
CISPLATIN;
DEXAMETHASONE;
DOCETAXEL;
FLUOROURACIL;
FOLINIC ACID;
GEMCITABINE;
IRINOTECAN;
METOCLOPRAMIDE;
ONDANSETRON;
PACLITAXEL;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
BILE DUCT CARCINOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG INDUCED DISEASE;
ESOPHAGUS CARCINOMA;
FEBRILE NEUTROPENIA;
FEMALE;
GASTROINTESTINAL CARCINOMA;
HOSPITALIZATION;
HUMAN;
LONG TERM CARE;
MALE;
METASTASIS;
NEPHROTOXICITY;
NEUTROPENIA;
PANCREAS CARCINOMA;
PRIORITY JOURNAL;
STOMACH CARCINOMA;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BILIARY TRACT NEOPLASMS;
CISPLATIN;
DIGESTIVE SYSTEM NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
ESOPHAGEAL NEOPLASMS;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HUMANS;
INFUSIONS, INTRAVENOUS;
LEUCOVORIN;
MALE;
MIDDLE AGED;
PANCREATIC NEOPLASMS;
STOMACH NEOPLASMS;
TREATMENT OUTCOME;
|
EID: 0034809199
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: 10.1016/S0959-8049(01)00180-0 Document Type: Article |
Times cited : (16)
|
References (24)
|